Home » Stocks » EVFM

Evofem Biosciences, Inc. (EVFM)

Stock Price: $2.29 USD 0.03 (1.33%)
Updated November 27, 1:00 PM EST - Market closed
After-hours: $2.25 -0.04 (-1.75%) Nov 27, 4:31 PM

Stock Price Chart

Key Info

Market Cap 179.13M
Revenue (ttm) 278,000
Net Income (ttm) -114.43M
Shares Out 78.22M
EPS (ttm) -1.93
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $2.29
Previous Close $2.26
Change ($) 0.03
Change (%) 1.33%
Day's Open 2.25
Day's Range 2.15 - 2.30
Day's Volume 2,187,094
52-Week Range 1.91 - 7.50

More Stats

Market Cap 179.13M
Enterprise Value 148.30M
Earnings Date (est) Feb 26, 2021
Ex-Dividend Date n/a
Shares Outstanding 78.22M
Float 76.27M
EPS (basic) -1.84
EPS (diluted) -1.93
FCF / Share -0.99
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 7.45M
Short Ratio 4.68
Short % of Float 9.76%
Beta -0.38
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 644.35
PB Ratio 4.77
Revenue 278,000
Operating Income -80.64M
Net Income -114.43M
Free Cash Flow -80.14M
Net Cash 30.83M
Net Cash / Share 0.39
Gross Margin -14.00%
Operating Margin -29,008.63%
Profit Margin -41,161.20%
FCF Margin -28,826.62%
ROA -66.54%
ROE -356.00%
ROIC -6,537.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (4)

Buy 2
Overweight 0
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

(205.68% upside)
Current: $2.29
Target: 7.00
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Gross Profit-------0.10
Operating Income-52.74-77.64-35.69-12.04-42.05-9.59-14.42-5.74
Net Income-80.03-126-105-13.02-43.16-10.82-15.02-7.83
Shares Outstanding40.2321.901.962.302.280.340.090.08
Earnings Per Share-1.99-5.74-55.78-5.66-18.91-32.16-175.98-93.90
Operating Cash Flow-55.10-56.50-19.24-16.25-37.91-9.57-12.90-7.40
Capital Expenditures-0.13-0.01-0.01--0.23-0.020.04-
Free Cash Flow-55.23-56.51-19.25-16.25-38.14-9.59-12.86-7.40
Cash & Equivalents24.111.761.7011.6837.9575.954.3611.14
Total Debt0.204.01--9.969.740.210.63
Net Cash / Debt23.91-2.251.7011.6827.9966.214.1610.51
Book Value15.64-23.36-29011.9123.8165.25-56.69-41.76
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Evofem Biosciences, Inc.
Country United States
Employees 53
CEO Saundra L. Pelletier

Stock Information

Ticker Symbol EVFM
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: EVFM


Evofem Biosciences, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, a vaginal pH regulator for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.